Location History:
- Assas, FR (2009 - 2016)
- Montpellier, FR (2015 - 2020)
Company Filing History:
6 out of 1,744 
5 out of 280 
2 out of 6 
Years Active: 2009-2020
Title: The Innovative Contributions of Thierry Chardes in Biotechnology
Introduction
Thierry Chardes is a prominent inventor based in Montpellier, France, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of seven patents, he has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Chardes's latest inventions include groundbreaking developments in the form of human monoclonal antibodies. One notable patent pertains to human anti-Cath-D neutralizing monoclonal antibodies, which inhibit both the catalytic activity of Cath-D and its binding to the LRP1 receptor. This invention details an isolated human monoclonal antibody or a fragment thereof, featuring specific variable regions essential for its function.
Another significant patent involves neuregulin allosteric anti-HER3 antibodies. This technology relates to non-competitive allosteric antibodies that enhance diagnostic and therapeutic methods for human HER3 receptors, highlighting Chardes's role in addressing critical healthcare challenges.
Career Highlights
Throughout his career, Thierry Chardes has been affiliated with esteemed institutions such as Université de Montpellier and INSERM (Institut National de la Santé et de la Recherche Médicale). His work at these institutions has allowed him to focus on cutting-edge research, yielding innovative products that have implications in therapeutic applications.
Collaborations
Chardes has collaborated with several notable individuals, including Andre Pelegrin and Christel Larbouret. These partnerships have further enriched his research endeavors, fostering an environment of innovation and creativity in the field of biotechnology.
Conclusion
With his seven patents and ongoing contributions to medical science, Thierry Chardes is a noteworthy inventor whose work continues to push the boundaries of biotechnology. His inventions not only demonstrate his expertise but also reflect the potential for innovation to transform healthcare practices globally.